600080.SH
ST金花
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 4.69
−2.09%Margins
Gross margin
77.5%
EBITDA margin
6.2%
EBIT margin
3.7%
Net margin
3.2%
FCF margin
-3.7%
1.1%
Return on equity
0.9%
Return on assets
1.3%
Return on invested capital
0.29x
Asset turnover
CNY 92.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026